These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [RIFOMYCIN SV IN LABORATORY TESTS]. NINNI A Arch Tisiol Mal Appar Respir; 1963 Oct; 18():919-44. PubMed ID: 14097338 [No Abstract] [Full Text] [Related]
5. [Antimycobacterial activity of rifamycin SV in vitro]. NITTI V Arch Tisiol Mal Appar Respir; 1963 Mar; 18():177-89. PubMed ID: 13938848 [No Abstract] [Full Text] [Related]
6. RELATIONSHIP OF ATYPICAL BOVINE AND PORCINE MYCOBACTERIA TO THOSE OF HUMAN ORIGIN. MALLMANN VH; MALLMANN WL; ROBINSON P Health Lab Sci; 1964 Jan; 1():11-20. PubMed ID: 14116581 [No Abstract] [Full Text] [Related]
7. [Contribution to the experimental study of the antitubercular activity of rifamycin SV]. RIST N; GRUMBACH F Arch Tisiol Mal Appar Respir; 1963 Mar; 18():304-5. PubMed ID: 13974058 [No Abstract] [Full Text] [Related]
8. [ON THE DIFFERENTIATION OF MYCOBACTERIUM TUBERCULOSIS AND MYCOBACTERIUM BOVIS WITH IN VITRO METHODS]. KAEPPLER W Prax Pneumol; 1964 Oct; 18():671-80. PubMed ID: 14323892 [No Abstract] [Full Text] [Related]
9. [INFLUENCE OF THE STATE OF BACTERIAL AGGREGATION ON THE ACTIVITY OF RIFOMYCIN SV IN VITRO]. NITTI V Arch Tisiol Mal Appar Respir; 1963 Jun; 18():594-600. PubMed ID: 14072544 [No Abstract] [Full Text] [Related]
10. STUDIES ON DIFFERENTIATION OF TUBERCLE BACILLI ISOLATED FROM HUMAN BEINGS, CATTLE AND POULTRY. II. ENZYMIC ACTIVITY. SZULGA T; MADRA J; KOWALCZYK H Arch Immunol Ther Exp (Warsz); 1963; 11():395-403. PubMed ID: 14059315 [No Abstract] [Full Text] [Related]
11. [ACTION OF BETAPROPIOLACTONE ON PYOGENIC BACTERIA AND ON MYCOBACTERIUM TUBERCULOSIS. ITS USE FOR THE PURIFICATION OF PATHOLOGICAL PRODUCTS AND FOR THE PREPARATION OF CULTURE MEDIA FOR MYCOBACTERIA]. TACQUET A; TISON F; POLSPOEL B Ann Inst Pasteur Lille; 1963; 14():139-43. PubMed ID: 14202534 [No Abstract] [Full Text] [Related]
12. EFFECT OF RIFAMYCIN SV ON THE INCORPORATION OF 32 P-PHOSPHATE, 35 S-SULFATE AND 14 C-ACETATE IN M. TUBERCULOSIS. TSUKAMURA M Jpn J Tuberc; 1964 Jul; 12():10-4. PubMed ID: 14178486 [No Abstract] [Full Text] [Related]
13. COMPARATIVE STUDY OF MYCOBACTERIUM GROWN IN VIVO AND IN VITRO. V. DIFFERENCES IN STAINING PROPERTIES. SEGAL W Am Rev Respir Dis; 1965 Feb; 91():285-7. PubMed ID: 14253181 [No Abstract] [Full Text] [Related]
14. [Observations in vitro on the antimycobacterial activity of rifamycin SV]. LUCCHESI M; ZUBIANI M; TERMINE A Ann Ist Carlo Forlanini; 1962; 22():431-40. PubMed ID: 13931420 [No Abstract] [Full Text] [Related]
15. POSSIBLE RELATIONSHIP BETWEEN THE VIRULENCE AND THE SULFUR CONTENT OF MYCOBACTERIA. TSUKAMURA M; TSUKAMURA S Acta Tuberc Pneumol Scand; 1964; 44():103-7. PubMed ID: 14162301 [No Abstract] [Full Text] [Related]
16. CLASSIFICATION AND IDENTIFICATION OF MYCOBACTERIA. II. TESTS EMPLOYING NITRATE AND NITRITE AS SUBSTRATE. WAYNE LG; DOUBEK JR Am Rev Respir Dis; 1965 May; 91():738-45. PubMed ID: 14280947 [No Abstract] [Full Text] [Related]
17. Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis. Heifets LB; Lindholm-Levy PJ; Flory MA Am Rev Respir Dis; 1990 Mar; 141(3):626-30. PubMed ID: 2155555 [TBL] [Abstract][Full Text] [Related]